Maximus (NYSE:MMS) Upgraded to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Maximus (NYSE:MMS – Free Report) from a hold rating to a buy rating in a report published on Saturday morning,Wall Street Zen reports.

A number of other research analysts also recently weighed in on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Maximus in a research note on Friday, November 13th. Zacks Research upgraded Maximus from a “strong sell” rating to a “hold” rating in a report on Thursday, October 1st. Two investment analysts have rated the stock with a Hold rating. According to data from MarketBeat, the company has an average rating of “Hold”.

Read Our Latest Stock Analysis on Maximus

Maximus Price Performance

Shares of NYSE MMS opened at $62.64 on Friday. The firm’s 50-day moving average price is $60.19 and its 200-day moving average price is $62.81. Maximus has a 1-year low of $51.04 and a 1-year high of $100.00. The firm has a market capitalization of $3.28 billion, a P/E ratio of 8.60 and a beta of 0.57. The company has a current ratio of 2.25, a quick ratio of 2.42 and a debt-to-equity ratio of 0.83.

Maximus (NYSE:MMS – Get Free Report) last issued its earnings results on Thursday, November 19th. The health services provider reported $2.11 EPS for the quarter, beating the consensus estimate of $1.85 by $0.26. The company had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.30 billion. Maximus had a return on equity of 25.47% and a net margin of 7.51%. The firm’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period last year, the business posted $1.62 EPS. Maximus has set its FY 2027 guidance at 7.500-8.000 EPS. Equities research analysts anticipate that Maximus will post 7.95 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Friday, November 13th. Maximus’s payout ratio is 19.50%.

Insider Buying and Selling

In other Maximus news, insider Michelle Link sold 3,208 shares of the company’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $54.23, for a total transaction of $173,969.84. Following the transaction, the insider owned 13,881 shares in the company, valued at approximately $752,766.63. This represents a 18.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.80% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. American Century Companies Inc. raised its holdings in shares of Maximus by 11.6% in the 3rd quarter. American Century Companies Inc. now owns 37,813 shares of the health services provider’s stock worth $2,011,000 after acquiring an additional 3,921 shares during the last quarter. Ruffer LLP boosted its stake in Maximus by 116.1% during the 3rd quarter. Ruffer LLP now owns 215,913 shares of the health services provider’s stock valued at $11,465,000 after purchasing an additional 115,980 shares during the last quarter. Allworth Financial LP boosted its stake in Maximus by 1,073.6% during the 3rd quarter. Allworth Financial LP now owns 4,706 shares of the health services provider’s stock valued at $250,000 after purchasing an additional 4,305 shares during the last quarter. Aquatic Capital Management LLC boosted its stake in Maximus by 119.9% during the 3rd quarter. Aquatic Capital Management LLC now owns 48,797 shares of the health services provider’s stock valued at $2,596,000 after purchasing an additional 26,603 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in Maximus by 56.4% during the 3rd quarter. Goldman Sachs Group Inc. now owns 1,001,596 shares of the health services provider’s stock valued at $53,275,000 after purchasing an additional 361,001 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Maximus

Investors following MMS have been watching these stories:

  • Positive Sentiment: Fiscal Q4 adjusted earnings were $2.11 per share, above consensus estimates of roughly $1.85–$1.88 and up from $1.62 a year earlier. Revenue of $1.30 billion was in line with estimates. Maximus tops Q4 earnings estimates
  • Positive Sentiment: Management forecast fiscal 2027 revenue of $5.5 billion–$5.7 billion, above the cited $5.4 billion analyst consensus, and free cash flow of $700 million–$800 million while integrating Agile Defense. Maximus forecasts fiscal 2027 free cash flow
  • Negative Sentiment: Quarterly revenue fell 1.3% year over year, and reports noted the shares had slipped below their 200-day moving average, highlighting concerns about near-term momentum. Maximus stock breaks below its 200-day moving average

Maximus Company Profile

(Get Free Report)

Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.

Further Reading

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.